MedaSync
PrivateLast Round
Strategic
Aug 27, 2025
Total Funding Raised
$570,000
Company Overview
MedaSync operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Strategic round in August 2025.
MedaSync is a healthcare technology company that provides an AI-powered reimbursement optimization software for skilled nursing facilities.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Patient Engagement, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedaSync Comparables
Compare MedaSync with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AKASA | 77% | |
| Aptarro | 77% | |
| Netsmart Technologies | 72% |
For institutional investors. Book with your work email.
MedaSync Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 27, 2025 | ||||
| Seed Round | Feb 16, 2024 | ||||
| Pre Seed | Jul 31, 2018 | ||||
| Grant | Jan 27, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MedaSync Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Valley Growth Ventures | Pre Seed |
| Youngstown Business Incubator | Grant |
| Burton D. Morgan Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
Omega Healthcare Investors led the strategic round.
- Aug 27, 2025
Megan Krull joins the Board of Directors.
For institutional investors. Book with your work email.
MedaSync Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MedaSync's valuation, stock price, and market status.
Is MedaSync a public or private company?
MedaSync is a private company.
What is the current stock price of MedaSync?
MedaSync is a private company, so its shares have no public market price. Caplight tracks MedaSync's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MedaSync worth (valuation)?
Valuation information for MedaSync is not publicly available.
Can I buy MedaSync stock?
MedaSync shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MedaSync's last funding round?
MedaSync's most recent funding round was Strategic on August 27, 2025.
Who are the main investors in MedaSync?
Key investors in MedaSync include Valley Growth Ventures.
Will MedaSync IPO soon?
No public IPO plans have been announced for MedaSync.
How can I track MedaSync secondary market activity?
Caplight tracks bids, offers, and trades in MedaSync's shares on secondary markets.